A biotechnology company developing immunotherapies for viral diseases is joining the ElevateBio consortium providing manufacturing for cell and gene therapies. . . . → Read More: Viral Disease Biotech Joins ElevateBio, Gains $120M
|
|||||
|
|
A new enterprise in the U.K. is creating treatments with stem cells to repair damaged nerve cells in the inner ear that causes hearing loss. . . . → Read More: Start-Up to Use Stem Cells for Hearing Loss 
A new company formed offering full-scale facilities to develop cell and gene therapy products spun-off from academic research labs. . . . → Read More: Company Helps Labs Build Gene, Cell Therapy Businesses 
So far this year, machine learning applications and platforms are gaining the most investment dollars worldwide for A.I., this weekend’s infographic. . . . → Read More: Infographic – Machine Learning Grabs Most A.I. Investments 
A collaboration between biopharmaceutical maker Gilead Sciences and biotechnology company Goldfinch Bio aims to develop precision medicines for treating various kidney diseases. . . . → Read More: Companies Partner on Kidney Disease in $2B Deal  Comments are closed  Intellectual property, Joint ventures/collaborations  biomedical, biotechnology, entrepreneurs, equity, investment, licensing, life sciences, pharmaceuticals, stem cells 
A new biotechnology enterprise plans to apply genetic analysis and the gene-editing technology Crispr to reduce the risk of coronary artery disease. . . . → Read More: Start-Up to Use Crispr for Heart Disease, Gains $59M One comment - (Comments are closed) Finance, Intellectual property biomedical, biotechnology, entrepreneurs, equity, genomics, heart disease, investment, licensing, life sciences, pharmaceuticals, university, venture capital 
Researchers developed a synthetic soft tissue for plastic and reconstructive surgery that in animal tests looks and performs more like real tissue. . . . → Read More: Synthetic Soft Tissue Developed for Surgery Comments are closed New products biomedical, biotechnology, engineering, entrepreneurs, equity, investment, licensing, life sciences, materials science, medical device, pharmaceuticals, physical sciences, preclinical, university, venture capital 
Venture capital investments worldwide declined in the first quarter of 2019, compared to the near record-setting pace of the last 3 months of 2018. . . . → Read More: Infographic – Venture Deals Cool Off in Q1 2019 One comment - (Comments are closed) Finance entrepreneurs, equity, investment, mathematics, venture capital 
Two biotechnology companies plan to develop new therapies mainly for eye and neurological diseases that silence genes responsible for those conditions. . . . → Read More: Biotechs Partner on Gene Silencing in $1.1B Deal Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, equity, genomics, investment, licensing, life sciences, pharmaceuticals 
A company creating cancer treatments that combine radiation therapy with the targeting of synthetic antibodies is raising $105 million in its second round of venture financing. . . . → Read More: Radiation-Antibody Biotech Raises $105M in Venture Funds Comments are closed Finance biomedical, biotechnology, Canada, cancer, clinical trials, entrepreneurs, equity, investment, life sciences, pharmaceuticals, university, venture capital |
||||
|
Copyright © 2019 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||